Market Research Report
Global Alopecia Treatment (Hair Loss) Market - Industry Trends and Forecast to 2027
|Global Alopecia Treatment (Hair Loss) Market - Industry Trends and Forecast to 2027|
Published: October 1, 2020
Data Bridge Market Research Private Limited
Content info: 576 Pages
Delivery time: Inquiry
Global alopecia treatment (hair loss) market is projected to register a CAGR of 6.0% in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.
Global Alopecia Treatment (Hair Loss) Market, By Disease Type (Non-Cicatricial Alopecia, Cicatricial Alopecia, Traction Alopecia and Others), Treatment (Localized Therapies, Systemic Therapies, Medical Devices and Herbal Treatment), Gender (Male and Female), Form (Oral, Topical and Parenteral), End User (Hospitals, Home Healthcare and Dermatology Centers), Distribution Channel (Direct Tender, Retail Sales and Pharmacies), Country (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Rest of Europe, Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Peru, Rest of South America, Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2027
Rise in prevalence of alopecia conditions
Increasing level of stress
Gerolymatos International SA
Lexington Intl., LLC.
Freedom Laser Therapy, Inc.
Taisho Pharmaceutical Holdings Co., Ltd.
Vita-Cos-Med Klett-Loch GmbH
Teva Pharmaceuticals USA, Inc. (a subsidiary of Teva Pharmaceuticals Industries Ltd.)
Par Pharmaceutical (a subsidiary of Endo International plc)
Dr. Reddy's Laboratories Ltd.
Zydus Pharmaceuticals, Inc. (a subsidiary of Zydus Cadila)
Johnson & Johnson Services, Inc.
Sun Pharmaceutical Industries Ltd.
Merck Sharp & Dohme Corp. (a subsidiary of Merck & Co., Inc.)
Perrigo Company plc
Viviscal Limited (a subsidiary of Church & Dwight Co., Inc.)
Dr. Kurt Wolff GmbH & Co. KG
Labo International S.r.l.
WON TECH Co., Ltd.